Medicare Prescription Drug, Improvement, and Modernization Act
GPTKB entity
Statements (74)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:legislation
|
| gptkbp:addresses |
health disparities
medication adherence |
| gptkbp:affects |
healthcare providers
healthcare costs low-income seniors |
| gptkbp:allows |
importation of drugs
appeals process for beneficiaries |
| gptkbp:amends |
gptkb:Medicare
|
| gptkbp:controversy |
cost of prescription drugs
|
| gptkbp:created |
Medicare Advantage plans
|
| gptkbp:date_enacted |
gptkb:2003
|
| gptkbp:enacted_by |
gptkb:United_States_Congress
|
| gptkbp:establishes |
gptkb:Medicare_Part_D_drug_plans
Medicare Advantage Special Needs Plans drug discount card Medicare Savings Programs Medicare Part D plans |
| gptkbp:establishes_requirements_for |
drug formularies
|
| https://www.w3.org/2000/01/rdf-schema#label |
Medicare Prescription Drug, Improvement, and Modernization Act
|
| gptkbp:impact |
Medicare beneficiaries
|
| gptkbp:includes |
gptkb:Medicare_Part_D
mental health services telehealth services patient education resources patient advocacy initiatives patient safety measures quality improvement programs outreach efforts safeguards against fraud health information technology initiatives out-of-pocket spending limits educational programs for beneficiaries |
| gptkbp:includes_provisions_for |
preventive services
|
| gptkbp:increased |
beneficiary choice
Medicare spending |
| gptkbp:increases_access_to |
gptkb:pharmaceuticals
|
| gptkbp:influences |
gptkb:Health_Insurance
political landscape future healthcare legislation |
| gptkbp:introduced_in |
gptkb:House_of_Representatives
|
| gptkbp:is_funded_by |
gptkb:federal_government
|
| gptkbp:is_opposed_by |
some healthcare advocates
|
| gptkbp:is_supported_by |
gptkb:pharmaceuticals
|
| gptkbp:prize_pool |
generic drugs
|
| gptkbp:promotes |
evidence-based practices
patient-centered care healthcare competition |
| gptkbp:provides |
prescription drug coverage
preventive health services transition assistance chronic care management access to specialty drugs assistance for low-income beneficiaries |
| gptkbp:reports_to |
drug prices
|
| gptkbp:requires |
transparency in pricing
annual enrollment period provider training stakeholder engagement. cultural competency training evaluation of program effectiveness coordination of care private insurance plans network adequacy standards coverage for off-label drug use data collection on drug utilization monitoring of drug interactions |
| gptkbp:signed_by |
gptkb:George_W._Bush
|
| gptkbp:supports |
chronic disease management
integrated care models research on drug effectiveness |
| gptkbp:bfsParent |
gptkb:George_W._Bush
gptkb:Medicare |
| gptkbp:bfsLayer |
3
|